Parth S Mehta
Biographic Data
| ID | 8258116 |
|---|---|
| NAME | Parth S Mehta |
| GIVEN NAMES | Parth S |
| FAMILY NAME | Mehta |
| SIGNATURE | MEHTA P S |
| AFFILIATIONS | Baylor College of Medicine |
| ORCID | 0000-0001-5695-6907 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Use of Paclitaxel to Successfully Treat Children, Adolescents, and Young Adults with Kaposi Sarcoma in Southwestern Tanzania
Treating Kaposi sarcoma (KS) in children, adolescents, and young adults (AYA) remains a challenge in low- and middle-income countries (LMIC) where chemotherapy options and availability are limited. We describe a retrospective cohort review of pediatric patients with KS treated with paclitaxel in Mbeya, Tanzania, between 1 March 2011 and 31 December 2019. Paclitaxel was given to patients who had KS relapse, a contraindication to bleomycin, vincris…
No prominent works on this page.
Use of Paclitaxel to Successfully Treat Children, Adolescents, and Young Adults with Kaposi Sarcoma in Southwestern Tanzania
Treating Kaposi sarcoma (KS) in children, adolescents, and young adults (AYA) remains a challenge in low- and middle-income countries (LMIC) where chemotherapy options and availability are limited. We describe a retrospective cohort review of pediatric patients with KS treated with paclitaxel in Mbeya, Tanzania, between 1 March 2011 and 31 December 2019. Paclitaxel was given to patients who had KS relapse, a contraindication to bleomycin, vincris…
Chemotherapy (1 work) · CNS Lymphoma Diagnosis and Treatment (1 work) · Cohort (1 work) · Contraindication (1 work) · Cyclophosphamide (1 work) · Internal Medicine (1 work) · Lymphoma Diagnosis and Treatment (1 work) · Medicine (1 work) · Paclitaxel (1 work) · Pathology (1 work)